Crestline Management, LP Heron Therapeutics, Inc. Transaction History

Crestline Management, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$4.63 - $9.94 $860,096 - $1.85 Million	-185,766 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$8.35 - $12.6 $692,390 - $1.04 Million	82,921 Added 80.63%	185,766 $1.7 Million
Q3 2021 Nov 12, 2021	BUY	$10.13 - $15.0 $1.04 Million - $1.54 Million	102,845 New	102,845 $1.1 Million
Q3 2018 Nov 14, 2018	SELL	$30.0 - $40.85 $2.27 Million - $3.09 Million	-75,645 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$26.4 - $42.0 $403,154 - $641,382	-15,271 Reduced 16.8%	75,645 $2.94 Million
Q1 2018 May 15, 2018	SELL	$18.43 - $28.8 $467,642 - $730,771	-25,374 Reduced 21.82%	90,916 $2.51 Million
Q4 2017 Feb 14, 2018	BUY	$14.8 - $18.85 $1.13 Million - $1.44 Million	76,212 Added 190.16%	116,290 $2.11 Million
Q3 2017 Nov 14, 2017	BUY	$14.65 - $16.85 $44,799 - $51,527	3,058 Added 8.26%	40,078 $647,000
Q2 2017 Aug 14, 2017	BUY	N/A	37,020	37,020 $513,000

179

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $184M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Crestline Management, LP, based on Form 13F filings with the SEC.

Stay updated on Crestline Management, LP with notifications on news.